On November 6, 2025, Vigonvita Life Sciences (stock code: 2630.HK) globally issued 17,597,800 H shares and listed on the Main Board of the Hong Kong Stock Exchange. The issuance price was HKD 33.37 per share, raising over HKD 580 million (before exercising the over-allotment option).